The pharmacodynamic equivalence of Orlistat 60 mg capsule. An open label, balanced, randomized, multiple-dose, cross-over pharmacodynamic end-point bioequivalence study in healthy, adult, human Asian Indian subjects under fed conditions

奥利斯特 生物等效性 医学 药效学 药代动力学 胶囊 粪便 胃排空 内科学 胃 药理学 动物科学 肥胖 减肥 生物 古生物学 植物
作者
Sudershan Kumar,Tausif Monif,Rachna Arora,Arshad Khuroo,Rakesh K. Jain,Simrit Reyar,Priya Ranjan Prasad Verma,Shireen Rao
出处
期刊:Clinical Research and Regulatory Affairs [Informa]
卷期号:30 (4): 55-62 被引量:3
标识
DOI:10.3109/10601333.2013.840311
摘要

Orlistat is a non-systemic treatment for obesity. The drug inhibits lipase in the gastrointestinal track mainly in the lumen of the stomach and small intestine by binding reversibly with the active site of gastric and pancreatic lipases, preventing the absorption of ∼30–35% of dietary fat. The undigested triglycerides are not absorbed, resulting in a caloric deficit and positive effect in weight control. The objective of this study was to assess the bioequivalence of orlistat administered as a generic and reference capsule formulations using a pharmacodynamic end-point. A total of 60 healthy volunteers followed a 5-day run-in diet period to be accustomed to a low fat diet; subjects were then randomized to receive under fed conditions oral doses of orlistat (60 mg) 3-times daily for 10 days as the generic (Ranbaxy Laboratories) or reference (Alli™, GlaxoSmithKline) capsule formulations. Subjects followed a standardized diet (2500 kcal/day, ∼30% as fat) for the entire study. Feces were collected over the last 2 days of the run-in period (baseline) and over the last 5 days of the two treatment periods. The amount of fat in meals and feces were assayed using the validated FTIR method with a limit of detection of 1.00 g%, respectively. Fecal fat excretion over 24 h (FFE24SS, calculated as the amount of fat excreted in feces adjusted by the amount of fat ingested) was used as a pharmacodynamic end-point to assess the bioequivalence between the two orlistat formulations. An analyses of variance (ANOVA) was performed on the log-transformed FFE24SS parameter to establish bioequivalence of the generic product with respect to the innovator formulation. Mean FFE24SS values at baseline and after repeated oral administrations of the generic and innovator formulations of orlistat were 0.88%, 40.55% and 40.54%, respectively. The ratio of least-squares means (LSM) of FFE24SS of the generic to the innovator formulation was 101.90%, with 90% confidence intervals of 97.94–106.01%. Orlistat was well tolerated by subjects in both periods of study and no serious adverse events were observed during the study. In conclusion, mean FFE24SS values were used as pharmacodynamic end-points to assess bioequivalence between two formulations of orlistat. Results from this study suggest that the test formulation of Orlistat capsule is bioequivalent to the reference marketed Alli™ when administered to healthy volunteers as a multiple dose under fed conditions.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顺利毕业发布了新的文献求助10
1秒前
技术的不能发表完成签到,获得积分10
1秒前
1秒前
西贝发布了新的文献求助10
1秒前
拼搏翠安发布了新的文献求助30
2秒前
欢呼的安白完成签到,获得积分10
2秒前
arpege完成签到,获得积分10
2秒前
2秒前
jj发布了新的文献求助10
2秒前
一页墨城完成签到,获得积分10
3秒前
3秒前
文静的念露完成签到,获得积分10
3秒前
3秒前
3秒前
lemon发布了新的文献求助20
3秒前
寂寞的小鱼的应助被yurig采纳,获得10
5秒前
5秒前
5秒前
发nature完成签到 ,获得积分10
5秒前
研友_LwlNdn的应助被123采纳,获得10
5秒前
6秒前
我是老大的应助被han采纳,获得10
6秒前
简单生活发布了新的文献求助10
6秒前
123qwe发布了新的文献求助10
7秒前
酷波er的应助被三石采纳,获得10
7秒前
z33发布了新的文献求助10
7秒前
8秒前
酷波er的应助被面条大王采纳,获得10
9秒前
Happyocean完成签到,获得积分10
9秒前
在水一方的应助被简隋英采纳,获得10
9秒前
852的应助被stone采纳,获得10
10秒前
10秒前
神宝嘎li发布了新的文献求助10
10秒前
10秒前
biancaliu发布了新的文献求助10
11秒前
lm0703完成签到,获得积分10
11秒前
12秒前
xxxxxxlp发布了新的文献求助10
12秒前
方丈渣渣完成签到,获得积分10
12秒前
wxh2077完成签到 ,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124